Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Exelixis Inc (NQ: EXEL ) 25.73 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Exelixis Inc < Previous 1 2 3 4 5 6 7 8 9 ... 13 14 Next > The Top 3 Biotech Stocks to Buy in April 2024 April 27, 2024 Learn about the top three biotech stocks to take advantage of these companies' promising futures and pharmaceutical advances. Via InvestorPlace Technical Signals Point to a Possible Breakout for EXELIXIS INC. April 24, 2024 EXELIXIS INC (NASDAQ:EXEL) Reveals Intriguing Technical Aspects. Here's What You Need to Know. Via Chartmill NASDAQ:EXEL is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. April 24, 2024 EXELIXIS INC (NASDAQ:EXEL): good value for what you're paying. Via Chartmill Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024 April 16, 2024 From Exelixis, Inc. Via Business Wire What Analysts Are Saying About Exelixis Stock April 10, 2024 Via Benzinga 2 Stocks Under $30 to Buy and Hold February 19, 2024 You don't need to be a millionaire to get started. Investing on a budget can work, too. Via The Motley Fool Recap: Exelixis Q4 Earnings February 06, 2024 Via Benzinga Earnings Scheduled For February 6, 2024 February 06, 2024 Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion. Via Benzinga Earnings Preview For Exelixis February 05, 2024 Via Benzinga NASDAQ:EXEL is an undervalued gem with solid fundamentals. March 29, 2024 For those who appreciate value investing, EXELIXIS INC (NASDAQ:EXEL) is a compelling option with its solid fundamentals. Via Chartmill 3 Biotech Stocks to Buy on the Dip: March 2024 March 27, 2024 Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three. Via InvestorPlace 4 Magnificent Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market March 23, 2024 Phenomenal deals can still be found, even with the Nasdaq Composite climbing to a new all-time high. Via The Motley Fool Topics Stocks Exposures US Equities 5 Biotechnology Stocks To Buy For A Stable Portfolio In 2024 March 09, 2024 Things have been looking better for the biotech industry in 2024 after a decent performance in 2023. Here is a look at some biotech stocks that may provide stability to one's portfolio throughout the... Via Talk Markets 2 Biotech Stocks to Buy Hand Over Fist in March March 08, 2024 These stocks are worth buying in most months of the year. Via The Motley Fool In the world of growth stocks, NASDAQ:EXEL shines as a value proposition. February 05, 2024 NASDAQ:EXEL, a growth stock which is not overvalued. Via Chartmill Breaking Down Exelixis: 7 Analysts Share Their Views January 30, 2024 Via Benzinga 3 Cutting-Edge Biotech Stocks Sitting on the Brink of Success March 06, 2024 With excellent financial health and great prospects, these three biotech stocks just may be the the next stars of the sector. Via InvestorPlace In a market where value is scarce, NASDAQ:EXEL offers a refreshing opportunity with its solid fundamentals. March 05, 2024 EXELIXIS INC (NASDAQ:EXEL) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. Via Chartmill 4 Thrilling Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market March 02, 2024 The growth-driven Nasdaq Composite has entered a new bull market, but plain-as-day deals can still be found. Via The Motley Fool Topics Stocks Exposures US Equities Exelixis to Webcast Fireside Chats as Part of Investor Conferences in March February 27, 2024 From Exelixis, Inc. Via Business Wire Around $4M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying February 23, 2024 Although U.S. stocks closed higher on Thursday, there were a few notable insider trades. Via Benzinga Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies February 14, 2024 EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:EXEL),(NYSE:PFE),(NASDAQ:BTAI),(NYSE:BMY) EQNX::TICKER_END Via FinancialNewsMedia The 3 Best Biotech Stocks to Buy in February 2024 February 13, 2024 The best biotech stocks to buy offer consistent growth opportunities and resist the influence of singular drug successes. Via InvestorPlace In a market where value is scarce, NASDAQ:EXEL offers a refreshing opportunity with its solid fundamentals. February 13, 2024 For those who appreciate value investing, EXELIXIS INC (NASDAQ:EXEL) is a compelling option with its solid fundamentals. Via Chartmill Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies February 14, 2024 From FN Media Group LLC Via GlobeNewswire 4 Appealing Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip February 10, 2024 The growth-driven Nasdaq Composite hasn't put the 2022 bear market entirely in the rearview mirror, which means opportunistic investors can still find bargains. Via The Motley Fool Topics Stocks Exposures US Equities 3 Attractive Medical Stocks To Buy After Earnings February 08, 2024 Quite a few top-rated stocks have highlighted this week’s earnings lineup with now appearing to be an ideal time to buy. Following their favorable quarterly results, here are 3 intriguing healthcare... Via Talk Markets Exelixis (EXEL) Q4 2023 Earnings Call Transcript February 06, 2024 EXEL earnings call for the period ending December 31, 2023. Via The Motley Fool Topics Earnings Exposures Financial Exelixis Announces Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Corporate Update February 06, 2024 From Exelixis, Inc. Via Business Wire Exelixis to Webcast Fireside Chats as Part of Investor Conferences in February February 01, 2024 From Exelixis, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 ... 13 14 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.